News of adverse reactions could raise hesitancy. But so could an appearance of complacency.This is an opinion column. The thoughts expressed are those of the author.I'm not sure the Food and Drug Administration and Centers for Disease Control have made the right choice by recommending pausing administration of the Johnson & Johnson COVID vaccine while rare but serious blood clotting events in women are investigated.
Or maybe officials will look at the data and decide there's insufficient cause to change guidance around J&J at all — that the link to these events is too unclear and the events too rare. In that case, the pause would still make clear to the public that they were monitoring the issue and showed willingness to change course if warranted, which they decided it wasn't.One of the most popular responses in surveys of people who are hesitating to take the COVID vaccines is they're.
We can't afford to remove the vaccine from use for months like was done with Tylenol then. But it shows how warning the public of potential, rare dangers can make them more inclined to believe when you say something is safe. " these rare events and make people more nervous about the vaccines than they would be if the FDA didn't act.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
White House says Johnson & Johnson pause 'will not have a significant impact on our vaccination plan'Business Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know. Is it possible to find a good guy on Twitter?
Source: BusinessInsider - 🏆 729. / 51 Read more »